E
Biotricity, Inc.
BTCY
$0.59
$0.060111.34%
E
Sell
3/14/2023Downgrade
Biotricity, Inc. (BTCY) was downgraded to E+ from D on 3/14/2023 due to a noticeable decline in the total return index, solvency index and volatility index. The quick ratio declined from 1.12 to 0.39, and debt to equity increased from -1.31 to -1.04.
Biotricity, Inc. (BTCY) was downgraded to E+ from D on 3/14/2023 due to a noticeable decline in the total return index, solvency index and volatility index. The quick ratio declined from 1.12 to 0.39, and debt to equity increased from -1.31 to -1.04.
D
Sell
2/9/2023Upgraded
Biotricity, Inc. (BTCY) was upgraded to D from E+ on 02/09/2023.
Biotricity, Inc. (BTCY) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Biotricity, Inc. (BTCY) was downgraded to E+ from D on 2/8/2023 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.06 to 1.12, and debt to equity increased from -2.13 to -1.31.
Biotricity, Inc. (BTCY) was downgraded to E+ from D on 2/8/2023 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.06 to 1.12, and debt to equity increased from -2.13 to -1.31.
D
Sell
5/16/2022Upgraded
Biotricity, Inc. (BTCY) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.
Biotricity, Inc. (BTCY) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.
E
Sell
5/13/2022Downgrade
Biotricity, Inc. (BTCY) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
Biotricity, Inc. (BTCY) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/5/2022Upgraded
Biotricity, Inc. (BTCY) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
Biotricity, Inc. (BTCY) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
Biotricity, Inc. (BTCY) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index and volatility index.
Biotricity, Inc. (BTCY) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index and volatility index.
D
Sell
11/9/2021Upgraded
Biotricity, Inc. (BTCY) was upgraded to D from E+ on 11/09/2021.
Biotricity, Inc. (BTCY) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Biotricity, Inc. (BTCY) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the growth index, efficiency index and valuation index. EBIT declined 96.95% from -$2.62M to -$5.17M, net income declined 90.11% from -$5.66M to -$10.75M, and operating cash flow declined 20.8% from -$2.68M to -$3.24M.
Biotricity, Inc. (BTCY) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the growth index, efficiency index and valuation index. EBIT declined 96.95% from -$2.62M to -$5.17M, net income declined 90.11% from -$5.66M to -$10.75M, and operating cash flow declined 20.8% from -$2.68M to -$3.24M.
D
Sell
2/18/2020Downgrade
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 2/18/2020 due to a significant decline in the efficiency index, growth index and valuation index. Operating cash flow declined 44.87% from -$1.46M to -$2.12M, net income declined 18.07% from -$2.01M to -$2.37M, and earnings per share declined from -$0.0563 to -$0.0662.
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 2/18/2020 due to a significant decline in the efficiency index, growth index and valuation index. Operating cash flow declined 44.87% from -$1.46M to -$2.12M, net income declined 18.07% from -$2.01M to -$2.37M, and earnings per share declined from -$0.0563 to -$0.0662.
D
Sell
1/21/2020Upgraded
Biotricity, Inc. (BTCY) was upgraded to D+ from D on 1/21/2020 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 5.78% from $327 to $345.9, EBIT increased 5.7% from -$2.06M to -$1.94M, and earnings per share increased from -$0.059 to -$0.0563.
Biotricity, Inc. (BTCY) was upgraded to D+ from D on 1/21/2020 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 5.78% from $327 to $345.9, EBIT increased 5.7% from -$2.06M to -$1.94M, and earnings per share increased from -$0.059 to -$0.0563.
D
Sell
8/19/2019Upgraded
Biotricity, Inc. (BTCY) was upgraded to D from D- on 8/19/2019 due to a significant increase in the efficiency index. Total capital increased 26.52% from -$910 to -$668.7.
Biotricity, Inc. (BTCY) was upgraded to D from D- on 8/19/2019 due to a significant increase in the efficiency index. Total capital increased 26.52% from -$910 to -$668.7.
D
Sell
8/7/2019Downgrade
Biotricity, Inc. (BTCY) was downgraded to D- from D on 8/7/2019 due to a decline in the total return index and volatility index.
Biotricity, Inc. (BTCY) was downgraded to D- from D on 8/7/2019 due to a decline in the total return index and volatility index.
D
Sell
7/17/2019Upgraded
Biotricity, Inc. (BTCY) was upgraded to D from D- on 7/17/2019 due to a noticeable increase in the growth index. Total revenue increased 51.45% from $117.6 to $178.1, earnings per share increased from -$0.0641 to -$0.0523, and operating cash flow increased 16.89% from -$1.39M to -$1.16M.
Biotricity, Inc. (BTCY) was upgraded to D from D- on 7/17/2019 due to a noticeable increase in the growth index. Total revenue increased 51.45% from $117.6 to $178.1, earnings per share increased from -$0.0641 to -$0.0523, and operating cash flow increased 16.89% from -$1.39M to -$1.16M.
D
Sell
2/20/2019Downgrade
Biotricity, Inc. (BTCY) was downgraded to D- from D on 2/20/2019 due to a significant decline in the efficiency index, solvency index and growth index. Total capital declined 32.47% from -$628.5 to -$832.6.
Biotricity, Inc. (BTCY) was downgraded to D- from D on 2/20/2019 due to a significant decline in the efficiency index, solvency index and growth index. Total capital declined 32.47% from -$628.5 to -$832.6.
D
Sell
1/7/2019Downgrade
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 1/7/2019 due to a decline in the volatility index.
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 1/7/2019 due to a decline in the volatility index.
D
Sell
12/21/2018Upgraded
Biotricity, Inc. (BTCY) was upgraded to D+ from D on 12/21/2018 due to an increase in the volatility index and valuation index.
Biotricity, Inc. (BTCY) was upgraded to D+ from D on 12/21/2018 due to an increase in the volatility index and valuation index.
D
Sell
12/6/2018Downgrade
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 12/6/2018 due to a decline in the total return index and volatility index.
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 12/6/2018 due to a decline in the total return index and volatility index.
D
Sell
11/19/2018Upgraded
Biotricity, Inc. (BTCY) was upgraded to D+ from D on 11/19/2018 due to an increase in the growth index, valuation index and volatility index. Total revenue increased 379.1% from $17.7 to $84.8, earnings per share increased from -$0.0758 to -$0.0663, and EBIT increased 10.07% from -$2.42M to -$2.18M.
Biotricity, Inc. (BTCY) was upgraded to D+ from D on 11/19/2018 due to an increase in the growth index, valuation index and volatility index. Total revenue increased 379.1% from $17.7 to $84.8, earnings per share increased from -$0.0758 to -$0.0663, and EBIT increased 10.07% from -$2.42M to -$2.18M.
D
Sell
10/9/2018Downgrade
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 10/9/2018 due to a major decline in the total return index, volatility index and valuation index.
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 10/9/2018 due to a major decline in the total return index, volatility index and valuation index.
D
Sell
8/17/2018Upgraded
Biotricity, Inc. (BTCY) was upgraded to D+ from D- on 8/17/2018 due to a significant increase in the efficiency index, growth index and valuation index. Earnings per share increased from -$0.1052 to -$0.0758, operating cash flow increased 26.14% from -$1.64M to -$1.21M, and net income increased 13.29% from -$2.79M to -$2.42M.
Biotricity, Inc. (BTCY) was upgraded to D+ from D- on 8/17/2018 due to a significant increase in the efficiency index, growth index and valuation index. Earnings per share increased from -$0.1052 to -$0.0758, operating cash flow increased 26.14% from -$1.64M to -$1.21M, and net income increased 13.29% from -$2.79M to -$2.42M.
D
Sell
8/14/2018Downgrade
Biotricity, Inc. (BTCY) was downgraded to D- from D on 8/14/2018 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 4.03 to 1.19.
Biotricity, Inc. (BTCY) was downgraded to D- from D on 8/14/2018 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 4.03 to 1.19.
D
Sell
2/16/2018Downgrade
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 2/16/2018 due to a significant decline in the efficiency index, valuation index and growth index. Net income declined 44.04% from -$1.45M to -$2.1M, EBIT declined 44.04% from -$1.45M to -$2.1M, and earnings per share declined from -$0.0476 to -$0.068.
Biotricity, Inc. (BTCY) was downgraded to D from D+ on 2/16/2018 due to a significant decline in the efficiency index, valuation index and growth index. Net income declined 44.04% from -$1.45M to -$2.1M, EBIT declined 44.04% from -$1.45M to -$2.1M, and earnings per share declined from -$0.0476 to -$0.068.
D
Sell
11/16/2017Upgraded
Biotricity, Inc. (BTCY) was upgraded to D+ from D on 11/16/2017 due to a significant increase in the efficiency index, solvency index and volatility index. The quick ratio increased from 0.25 to 0.83, total capital increased 97.3% from -$3.54M to -$95.4, and net income increased 36.83% from -$2.3M to -$1.45M.
Biotricity, Inc. (BTCY) was upgraded to D+ from D on 11/16/2017 due to a significant increase in the efficiency index, solvency index and volatility index. The quick ratio increased from 0.25 to 0.83, total capital increased 97.3% from -$3.54M to -$95.4, and net income increased 36.83% from -$2.3M to -$1.45M.
D
Sell
10/20/2017None
Biotricity, Inc. (BTCY) was downgraded to D from U on 10/20/2017.
Biotricity, Inc. (BTCY) was downgraded to D from U on 10/20/2017.
OTC PK
03/12/2025 2:44PM Eastern
Quotes delayed
